These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30361764)

  • 1. Cough Effectiveness and Pulmonary Hygiene Practices in Patients with Pompe Disease.
    Pitts T; Bordelon R; Huff A; Byrne BJ; Smith BK
    Lung; 2019 Feb; 197(1):1-8. PubMed ID: 30361764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
    Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
    Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IPPB-assisted coughing in neuromuscular disorders.
    Dohna-Schwake C; Ragette R; Teschler H; Voit T; Mellies U
    Pediatr Pulmonol; 2006 Jun; 41(6):551-7. PubMed ID: 16617451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining.
    Jones HN; Crisp KD; Robey RR; Case LE; Kravitz RM; Kishnani PS
    Mol Genet Metab; 2016 Feb; 117(2):120-8. PubMed ID: 26381077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted Hypercapnic Respiratory Drive Response in Subjects With Late-Onset Pompe Disease.
    De Vito EL; Monteiro SG; Aruj PK
    Respir Care; 2016 Jul; 61(7):930-5. PubMed ID: 27006351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality.
    Aslan GK; Huseyinsinoglu BE; Oflazer P; Gurses N; Kiyan E
    Lung; 2016 Aug; 194(4):555-61. PubMed ID: 27106274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peak Cough Flow Fails to Detect Upper Airway Collapse During Negative Pressure Titration for Cough-Assist.
    Lacombe M; Boré A; Amo Castrillo LD; Boussaïd G; Falaize L; Vlachos E; Orlikowski D; Prigent H; Lofaso F
    Arch Phys Med Rehabil; 2019 Dec; 100(12):2346-2353. PubMed ID: 31351076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression from respiratory dysfunction to failure in late-onset Pompe disease.
    Berger KI; Chan Y; Rom WN; Oppenheimer BW; Goldring RM
    Neuromuscul Disord; 2016 Aug; 26(8):481-9. PubMed ID: 27297666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease.
    Boentert M; Prigent H; Várdi K; Jones HN; Mellies U; Simonds AK; Wenninger S; Barrot Cortés E; Confalonieri M
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy.
    Gauld LM; Boynton A
    Pediatr Pulmonol; 2005 May; 39(5):457-60. PubMed ID: 15765540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness.
    Jones HN; Crisp KD; Moss T; Strollo K; Robey R; Sank J; Canfield M; Case LE; Mahler L; Kravitz RM; Kishnani PS
    J Pediatr Rehabil Med; 2014; 7(3):255-65. PubMed ID: 25260508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory failure in Pompe disease: treatment with noninvasive ventilation.
    Mellies U; Stehling F; Dohna-Schwake C; Ragette R; Teschler H; Voit T
    Neurology; 2005 Apr; 64(8):1465-7. PubMed ID: 15851748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum insufflation capacity and peak cough flow in neuromuscular disorders.
    Mellies U; Goebel C
    Ann Am Thorac Soc; 2014 Dec; 11(10):1560-8. PubMed ID: 25384211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease.
    van der Beek NA; van Capelle CI; van der Velden-van Etten KI; Hop WC; van den Berg B; Reuser AJ; van Doorn PA; van der Ploeg AT; Stam H
    Mol Genet Metab; 2011; 104(1-2):129-36. PubMed ID: 21763167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic respiratory muscle function in late-onset Pompe disease.
    Smith BK; Allen S; Mays S; Martin AD; Byrne BJ
    Sci Rep; 2019 Dec; 9(1):19006. PubMed ID: 31831753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement therapy for infantile-onset pompe disease: curse or cure?
    Willems J; Petros A; Brierley J
    Neurology; 2008 Jul; 71(5):380-1. PubMed ID: 18663187
    [No Abstract]   [Full Text] [Related]  

  • 17. Titration of Mechanical Insufflation-Exsufflation Optimal Pressure Combinations in Neuromuscular Diseases by Flow/Pressure Waveform Analysis.
    Lalmolda C; Prados H; Mateu G; Noray M; Pomares X; Luján M
    Arch Bronconeumol (Engl Ed); 2019 May; 55(5):246-251. PubMed ID: 30598235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of air stacking and abdominal compression for cough assistance in people with complete tetraplegia.
    Torres-Castro R; Vilaró J; Vera-Uribe R; Monge G; Avilés P; Suranyi C
    Spinal Cord; 2014 May; 52(5):354-7. PubMed ID: 24614852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered activation of the diaphragm in late-onset Pompe disease.
    Smith BK; Corti M; Martin AD; Fuller DD; Byrne BJ
    Respir Physiol Neurobiol; 2016 Feb; 222():11-5. PubMed ID: 26612101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of cough efficiency in Duchenne muscular dystrophy.
    LoMauro A; Romei M; D'Angelo MG; Aliverti A
    Pediatr Pulmonol; 2014 Apr; 49(4):357-65. PubMed ID: 23852963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.